ATS Medical Announces FDA Clearance of the ATS Simulus Adjustable Annuloplasty Band

Share this story with your network

MINNEAPOLIS, May 12 /PRNewswire-FirstCall/ — ATS Medical, Inc. (Nasdaq: ATSI – News), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced FDA clearance of the ATS Simulus® Adjustable Annuloplasty Band.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

The ATS Simulus Adjustable Annuloplasty Band is the next product in a portfolio of mitral valve repair products developed and commercialized through the Company’s partnership with Genesee BioMedical.

This band respects the natural motion of the mitral annulus and its proximity to the aortic valve allowing for a safe, physiologic valve repair. The simple but elegant design of the ATS Simulus Adjustable Band allows the surgeon to make asymmetric or symmetric adjustments to the posterior segment of the mitral valve annulus at any time during the procedure, optimizing the repair. This product is also indicated for tricuspid valve repair, where a band is the preferred annuloplasty device.

Annuloplasty rings and bands are used in those cases where repair of a patient’s heart valve is preferable to replacement of the valve. The ATS Simulus Adjustable Band provides additional options for surgeons in terms of different exposures, double valve procedures and minimally invasive implants.

Leave a Comment

Your email address will not be published. Required fields are marked *

*